T2 Heart Mapping in AMI Population for the Prediction of Short Term Major

Status Withdrawn

Clinical Trial Summary

A novel Cardiac MRI sequence, developed by Dr. Maria Altbach (Double Inversion radial fast Spin Echo T2 mapping), has been tested clinically. It demonstrated a high sensitivity to the heart muscle swelling ("edema") in different types of heart injury, including heart attacks.

The investigators propose to use T2-Map methodology in patients with acute heart attacks and to compare value of this method with other clinical and imaging parameters in predicting short-term (30 day) clinical outcomes of these patients.

If successful, the project will provide an effective risk-stratification tool to identify patients with heart attack as a result of atherosclerotic disease, who require more aggressive therapeutic approach and closer follow-up after initial hospitalization.

Clinical Trial Description

In the initial feasibility project, a novel Cardiac MRI sequence (Double Inversion radial fast Spin Echo T2 mapping)developed by Dr. Maria Altbach at the University of Arizona, has been tested clinically. It demonstrated a high sensitivity to the heart muscle swelling ("edema") in different types of heart injury, including heart attacks. The investigators have successfully tested the reproducibility of the new method in a series of healthy volunteers. The Phase I study revealed a robust clinical performance of the T2-Map sequence in multiple cardiac disorders.

Based on these promising results, presented on several international Cardiac Imaging meetings, the investigators propose to use T2-Map methodology in patients with acute heart attacks and to compare value of this method with other clinical and imaging parameters in predicting short-term (30 day) clinical outcomes of these patients.

If successful, the project will provide an effective risk-stratification tool to identify patients with heart attack as a result of atherosclerotic disease, who require more aggressive therapeutic approach and closer follow-up after initial hospitalization. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01796743
Study type	Observational
Source	University of Arizona
Contact
Status	Withdrawn
Phase	N/A
Start date	February 2013
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05759078` - Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion	Phase 4
Completed	`NCT06408636` - Prognostic Role of LA Strain in Acute Myocardial Infarction
Recruiting	`NCT06038994` - Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction
Recruiting	`NCT04968808` - Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)	N/A
Completed	`NCT03338504` - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting	`NCT03317691` - The ALERT-Pilot Study	N/A
Active, not recruiting	`NCT05077683` - Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF	Phase 3
Recruiting	`NCT03957005` - Cardiovascular Risk Assessment Model in Patients With MI
Enrolling by invitation	`NCT05955950` - Gratitude Intervention in Promoting Self-care in Patients With Myocardial Infarction	N/A
Active, not recruiting	`NCT06141252` - Benefit of Hypothermia in OHCA Complicating AMI	N/A
Not yet recruiting	`NCT04560023` - Effectiveness of Multimedia Exposure in Patients Transferred to Hospital Suffering From Acute Myocardial Infarction	N/A
Terminated	`NCT03809689` - Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET	N/A
Recruiting	`NCT06430892` - RAPID-POP a Randomized Controlled Trial	N/A
Completed	`NCT05118009` - Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)	N/A
Active, not recruiting	`NCT04753749` - Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy	N/A
Completed	`NCT04769219` - Secondary Prevention Education After Acute Myocardial Infarction	N/A
Active, not recruiting	`NCT05350969` - Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction	Phase 2
Recruiting	`NCT05999110` - Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR)	N/A
Completed	`NCT04167904` - Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Not yet recruiting	`NCT04989777` - IABP In AMI Patients With SCAI-B Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

T2 Heart Mapping in AMI Population for the Prediction of Short Term Major Adverse Cardiovascular Events — T2 AMI MRI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms